000 01658 a2200505 4500
005 20250513043726.0
264 0 _c19950727
008 199507s 0 0 eng d
022 _a0003-4967
024 7 _a10.1136/ard.54.5.382
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMuscat, C
245 0 0 _aLong term treatment of rheumatoid arthritis with high doses of intravenous immunoglobulins: effects on disease activity and serum cytokines.
_h[electronic resource]
260 _bAnnals of the rheumatic diseases
_cMay 1995
300 _a382-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aArthritis, Rheumatoid
_ximmunology
650 0 4 _aCytokines
_xblood
650 0 4 _aDrug Administration Schedule
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulins
_xadministration & dosage
650 0 4 _aInjections, Intravenous
650 0 4 _aInterferon-gamma
_xanalysis
650 0 4 _aInterleukin-1
_xanalysis
650 0 4 _aInterleukin-6
_xanalysis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aReceptors, Interleukin-2
_xanalysis
650 0 4 _aTime Factors
650 0 4 _aTumor Necrosis Factor-alpha
_xanalysis
700 1 _aBertotto, A
700 1 _aErcolani, R
700 1 _aBistoni, O
700 1 _aAgea, E
700 1 _aCesarotti, M
700 1 _aFiorucci, G
700 1 _aSpinozzi, F
700 1 _aGerli, R
773 0 _tAnnals of the rheumatic diseases
_gvol. 54
_gno. 5
_gp. 382-5
856 4 0 _uhttps://doi.org/10.1136/ard.54.5.382
_zAvailable from publisher's website
999 _c7793401
_d7793401